Academic Bibliography

Search 200 years of publications by Ghent University researchers.

prof. dr. Sarah Gerlo

Faculty of Medicine and Health Sciences > Department of Biomolecular Medicine

Work address: C. Heymanslaan 10, ingang 38 (MRB2)
9000 Gent
Email: Sarah.Gerlo@UGent.be
ORCID iD: 0000-0002-1628-6088

Show Sort by

Add to list
- Journal Article
- open access
Organ-specific genome diversity of replication-competent SARS-CoV-2

Jolien Van Cleemput (UGent) , Willem van Snippenberg (UGent) , Laurens Lambrechts (UGent) , Amélie Dendooven (UGent) , Valentino D'Onofrio (UGent) , Liesbeth Couck (UGent) , Wim Trypsteen (UGent) , Jan Vanrusselt, Sebastiaan Theuns (UGent) , Nick Vereecke (UGent) , et al.

(2021) Nature Communications.
Add to list
- Journal Article
- A1
- open access
Selective IL-1 activity on CD8+ T cells empowers antitumor immunity and synergizes with neovasculature-targeted TNF for full tumor eradication

Bram Van Den Eeckhout (UGent) , Leander Huyghe (UGent) , Sandra Van Lint (UGent) , Elianne Burg (UGent) , Stéphane Plaisance, Frank Peelman (UGent) , Anje Cauwels (UGent) , Gilles Uzé, Niko Kley, Sarah Gerlo (UGent) , et al.

(2021) JOURNAL FOR IMMUNOTHERAPY OF CANCER. 9(11).
Add to list
- Journal Article
- A1
COVID‐19 vaccination with BNT162b2 and ChAdOx1 vaccines has the potential to induce nasal neutralizing antibodies

Jozefien Declercq (UGent) , Els Tobback (UGent) , Stijn Vanhee (UGent) , Natalie De Ruyck (UGent) , Sarah Gerlo (UGent) , Philippe Gevaert (UGent) and Linos Vandekerckhove (UGent)

(2021) ALLERGY.
Add to list
- Conference Paper
- C3
Cytokine and chemokine dynamics in acute HIV infection and the impact of early ART initiation

Jozefien De Clercq (UGent) , Grégoire Thomas (UGent) , Sarah Gerlo (UGent) and Linos Vandekerckhove (UGent)

(2021) HIV Pathogenesis and Cure, joint meeting with HIV Vaccines, Abstracts.
Add to list
- Journal Article
- A1
- open access
Interleukin-1 as innate mediator of T cell immunity

Bram Van Den Eeckhout (UGent) , Jan Tavernier (UGent) and Sarah Gerlo (UGent)

(2021) FRONTIERS IN IMMUNOLOGY. 11.
Add to list
- Journal Article
- A1
- open access
On the whereabouts of SARS-CoV-2 in the human body : a systematic review

Wim Trypsteen (UGent) , Jolien Van Cleemput (UGent) , Willem van Snippenberg (UGent) , Sarah Gerlo (UGent) and Linos Vandekerckhove (UGent)

(2020) PLOS PATHOGENS. 16(10).
Add to list
- Journal Article
- A1
- open access
Specific targeting of IL-1β activity to CD8+ T cells allows for safe use as a vaccine adjuvant

Bram Van Den Eeckhout (UGent) , Lien Van Hoecke (UGent) , Elianne Burg (UGent) , Sandra Van Lint (UGent) , Frank Peelman (UGent) , Niko Kley, Gilles Uzé, Xavier Saelens (UGent) , Jan Tavernier (UGent) and Sarah Gerlo (UGent)

(2020) NPJ VACCINES. 5(1).
Add to list
- Conference Paper
- C3
Selected IL-1 activity on CD8+ T cells allows for safe enhancement of cellular immune responses

Bram Van Den Eeckhout (UGent) , Lien Van Hoecke (UGent) , Elianne Burg (UGent) , Sandra Van Lint (UGent) , Frank Peelman (UGent) , Niko Kley, Gilles Uzé, Xavier Saelens (UGent) , Jan Tavernier (UGent) and Sarah Gerlo (UGent)

(2020) T Cell Memory, Abstracts.
Add to list
- Conference Paper
- C3
Towards the use of interleukin-1β as vaccine adjuvant

Bram Van Den Eeckhout (UGent) , Lien Van Hoecke (UGent) , Elianne Burg (UGent) , Sandra Van Lint (UGent) , Frank Peelman (UGent) , Xavier Saelens (UGent) , Jan Tavernier (UGent) and Sarah Gerlo (UGent)

(2019) The 1918 influenza pandemic: historical and biomedical reflections, VIB conference, Abstracts.
Add to list
- Conference Paper
- C3
IL-1β AcTaleukins : towards potent yet safe adjuvants for tumor vaccination

Bram Van Den Eeckhout (UGent) , Elianne Burg (UGent) , Anje Cauwels (UGent) , Frank Peelman (UGent) , Sandra Van Lint (UGent) , Jan Tavernier (UGent) and Sarah Gerlo (UGent)

(2018) Dendritic Cells, 15th International symposium, Abstracts.

1
2
3
4
…
6
7

Next →